遗传性下调白介素-6信号与较低衰弱风险相关
本研究利用与C反应蛋白水平降低相关的IL-6受体位点遗传变异作为IL-6信号下调的遗传代理,在HELIAD队列11,171人中行两样本孟德尔随机化分析,发现遗传倾向的IL-6信号下调与较低衰弱风险相关,并在UK Biobank中复制了s-IL-6R水平加权结果。
要点
- 遗传代理的IL-6信号下调与较低衰弱风险相关,提示潜在因果效应。
- 排除抑郁或认知相关FI条目及按年龄、性别分层后结果仍稳健。
- 遗传性升高的s-IL-6R水平与衰弱呈负相关,并在UK Biobank与HELIAD荟萃分析中显著。
核心结论
- 结果支持IL-6信号对衰弱存在潜在因果效应,并提示下调IL-6水平可能降低衰弱风险。
研究设计与样本
- 两样本孟德尔随机化研究,选取IL-6R位点附近与CRP水平降低相关的遗传变异作为IL-6信号下调的遗传代理。
- 主要分析在HELIAD研究的11,171名个体中进行,衰弱状态以衰弱指数(FI)定义。
- 尝试在UK Biobank数据集中进行复制。
主要发现
- 以CRP水平加权的IL-6信号下调遗传倾向与较低衰弱风险相关,分类变量分析OR(95%CI)=0.15(-3.39,-0.40),P=0.013。
- 连续变量分析beta(se)=-0.09(0.003),P=0.0009。
- 敏感性分析显示不同MR方法估计相似,无水平多效性或异质性证据。
- 排除抑郁或认知相关FI条目及按性别或年龄分层后结果仍稳健。
- 遗传性升高的s-IL-6R水平与衰弱负相关,该发现在UK Biobank与HELIAD队列荟萃分析中仍显著。
关键数值与推荐
- 衰弱状态以衰弱指数(FI)定义。
- 遗传代理为IL-6R位点附近与CRP水平降低相关的遗传变异。
- 复制分析使用以s-IL-6R水平加权的替代工具。
临床怎么用
- 结果提示IL-6信号通路可能是衰弱预防或干预的潜在靶点,但尚需进一步研究验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: numerous studies point towards a critical role of Interleukin 6 (IL-6) pathway in frailty pathogenesis yet the causal relationship between the two remains elusive. METHODS: we selected genetic variants near the IL-6 receptor locus (IL-6R) associated with reduced C-reactive protein (CRP) levels, a downstream effector of IL-6 pathway, and we used them as genetic proxies of IL-6 signalling downregulation. We then performed a two-sample Mendelian randomisation (MR) to investigate the association with frailty status, as defined by the Frailty Index (FI) in 11,171 individuals from the Hellenic Longitudinal Investigation of Ageing and Diet (HELIAD) study. MR analysis was repeated after excluding depression or cognition-related FI items as well as following age or sex stratification. Association with frailty was also examined using an alternative instrument, weighted on s-IL-6R levels. Replication was attempted in UK Biobank dataset. RESULTS: genetic predisposition to IL-6 signalling downregulation, weighted on CRP levels, was associated with lower risk of frailty, inserted either as categorical (odds ratio [95% confidence interval] = 0.15 [-3.39, -0.40], P = 0.013) or continuous variable (beta [se] = -0.09 [0.003], P = 0.0009). Sensitivity analyses revealed similar estimates across different MR methods with no evidence for horizontal pleiotropy or heterogeneity. Results remained robust after exclusion of depression or cognition-related FI items and following sex or age stratification. Genetically increased s-IL-6R levels were negatively correlated with frailty and this finding remained significant in a meta-analysis of UK Biobank and HELIAD cohorts. CONCLUSION: our results support a potential causal effect of IL-6 signalling on frailty and further suggest that downregulation of IL-6 levels may reduce frailty risk.
引用
- Mourtzi N, Georgakis M, Ntanasi E, et al. Genetically downregulated Interleukin-6 signalling is associated with a lower risk of frailty. Age Ageing. 2023. PMID: 36729470. doi:10.1093/ageing/afac318
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。